Oncotarget

Clinical Research Papers:

Lymph node ratio is a prognostic factor for non-small cell lung cancer

Guangyuan Sun, Lei Xue, Mingdong Wang and Xuewei Zhao _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:33912-33918. https://doi.org/10.18632/oncotarget.5669

Metrics: PDF 996 views  |   HTML 1504 views  |   ?  


Abstract

Guangyuan Sun1, Lei Xue1, Mingdong Wang1 and Xuewei Zhao1

1 Department of Thoracic and Cardiovascular Surgery, Changzheng Hospital, the Second Military Medical University, Shanghai, China

Correspondence to:

Xuewei Zhao, email:

Keywords: non-small cell lung cancer, lymph node ratio, association, meta-analysis

Received: July 09, 2015 Accepted: August 22, 2015 Published: September 15, 2015

Abstract

The lymph node ratio (LNR) is defined as the number of pathologically positive LNs divided by the number of LNs examined. Some studies reported that high LNR was significantly associated with poor survival of non-small cell lung cancer (NSCLC). However, other studies could not confirm this result. PubMed, Embase, and the Cochrane Register of Controlled Trials were searched for relevant studies published up to July 2015. Primary outcome was the relationship between LNR and disease-specific survival (DSS) and overall survival (OS). Twelve studies with 25138 NSCLC patients were included in this meta-analysis. Higher LNR was significantly associated with decreased OS (HR = 1.93; 95% CI 1.64 – 2.28; P < 0.00001) and DSS (HR = 1.82; 95% CI 1.55 – 2.14; P < 0.00001). In the subgroup analysis, N1 stage NSCLC patients with higher LNR also showed decreased OS (HR = 1.60; 95% CI 1.25 – 2.28; P = 0.0002) and DSS (HR = 1.82; 95% CI 1.55 – 2.21; P < 0.0001). This meta-analysis indicated that LNR was an independent predictor of survival in patients with NSCLC.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 5669